DHX36 prevents the accumulation of translationally inactive mRNAs with G4-structures in untranslated regions.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
03 06 2019
Historique:
received: 04 12 2018
accepted: 07 05 2019
entrez: 5 6 2019
pubmed: 5 6 2019
medline: 25 6 2019
Statut: epublish

Résumé

Translation efficiency can be affected by mRNA stability and secondary structures, including G-quadruplex structures (G4s). The highly conserved DEAH-box helicase DHX36/RHAU resolves G4s on DNA and RNA in vitro, however a systems-wide analysis of DHX36 targets and function is lacking. We map globally DHX36 binding to RNA in human cell lines and find it preferentially interacting with G-rich and G4-forming sequences on more than 4500 mRNAs. While DHX36 knockout (KO) results in a significant increase in target mRNA abundance, ribosome occupancy and protein output from these targets decrease, suggesting that they were rendered translationally incompetent. Considering that DHX36 targets, harboring G4s, preferentially localize in stress granules, and that DHX36 KO results in increased SG formation and protein kinase R (PKR/EIF2AK2) phosphorylation, we speculate that DHX36 is involved in resolution of rG4 induced cellular stress.

Identifiants

pubmed: 31160600
doi: 10.1038/s41467-019-10432-5
pii: 10.1038/s41467-019-10432-5
pmc: PMC6547686
doi:

Substances chimiques

RNA, Messenger 0
Untranslated Regions 0
EIF2AK2 protein, human EC 2.7.11.1
eIF-2 Kinase EC 2.7.11.1
DHX36 protein, human EC 3.6.1.-
DEAD-box RNA Helicases EC 3.6.4.13

Types de publication

Journal Article Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2421

Subventions

Organisme : Deutsche Forschungsgemeinschaft (German Research Foundation)
ID : EXC2151 - 390873048
Pays : International
Organisme : EC | EU Framework Programme for Research and Innovation H2020 | H2020 Euratom (H2020 Euratom Research and Training Programme 2014-2018)
ID : 638988-G4DSB
Pays : International

Références

Nucleic Acids Res. 2012 Jun;40(11):4727-41
pubmed: 22351747
Nat Chem. 2013 Mar;5(3):182-6
pubmed: 23422559
RNA. 2014 Jul;20(7):1129-41
pubmed: 24865610
Cell. 2010 Apr 2;141(1):129-41
pubmed: 20371350
Cell. 2012 Jul 20;150(2):279-90
pubmed: 22817891
Nature. 2018 Jun;558(7710):465-469
pubmed: 29899445
Nucleic Acids Res. 2009 Jul;37(Web Server issue):W202-8
pubmed: 19458158
Mol Cell. 2017 Nov 16;68(4):808-820.e5
pubmed: 29129640
Nucleic Acids Res. 2008 Nov;36(19):6260-8
pubmed: 18832370
Cold Spring Harb Perspect Biol. 2018 Jul 2;10(7):
pubmed: 29967010
Biochim Biophys Acta. 2013 Aug;1829(8):854-65
pubmed: 23567047
Mol Cell. 2018 May 17;70(4):650-662.e8
pubmed: 29731414
RNA. 2008 Jul;14(7):1290-6
pubmed: 18515550
Nature. 2017 Mar 23;543(7646):568-572
pubmed: 28297718
Nucleic Acids Res. 2011 Nov;39(21):9390-404
pubmed: 21846770
Nucleic Acids Res. 2012 May;40(9):4110-24
pubmed: 22238380
J Biol Chem. 2008 Dec 12;283(50):34626-34
pubmed: 18842585
Translation (Austin). 2016 Oct 4;4(2):e1244031
pubmed: 28090421
Nature. 2013 May 23;497(7450):458-62
pubmed: 23657261
Nature. 2006 Mar 23;440(7083):561-4
pubmed: 16554824
Genome Biol. 2018 Dec 27;19(1):229
pubmed: 30591072
Biochem Soc Trans. 2017 Oct 15;45(5):1173-1182
pubmed: 28939694
Mol Cell. 2004 Jan 16;13(1):101-11
pubmed: 14731398
Wiley Interdiscip Rev RNA. 2012 Jul-Aug;3(4):495-507
pubmed: 22488917
Nat Protoc. 2012 Mar 01;7(3):562-78
pubmed: 22383036
Nat Chem Biol. 2007 Apr;3(4):218-21
pubmed: 17322877
Adv Biochem Eng Biotechnol. 2020;170:1-20
pubmed: 28382477
Virus Res. 2009 Feb;139(2):193-208
pubmed: 18621088
Genome Biol. 2011 Aug 18;12(8):R79
pubmed: 21851591
Cell Rep. 2015 Oct 27;13(4):723-732
pubmed: 26489465
Nat Protoc. 2014 Sep;9(9):2045-60
pubmed: 25079428
Annu Rev Genet. 2016 Nov 23;50:235-266
pubmed: 27648642
Nature. 1988 Jul 28;334(6180):364-6
pubmed: 3393228
RNA. 2008 Dec;14(12):2580-96
pubmed: 18978028
Nucleic Acids Res. 2014 Mar;42(5):3346-61
pubmed: 24369427
RNA. 2017 Aug;23(8):1172-1179
pubmed: 28473452
Bioinformatics. 2011 Jun 15;27(12):1653-9
pubmed: 21543442
Science. 2009 Apr 10;324(5924):218-23
pubmed: 19213877
Cell Rep. 2017 Mar 21;18(12):2979-2990
pubmed: 28329689
Nat Biotechnol. 2008 Dec;26(12):1367-72
pubmed: 19029910
Cell Death Dis. 2015 Jan 22;6:e1610
pubmed: 25611385
Nucleic Acids Res. 2012 Feb;40(3):1033-49
pubmed: 21993297
J Biol Chem. 2016 Aug 19;291(34):18041-57
pubmed: 27369081
J Mol Biol. 2017 Jul 7;429(14):2127-2147
pubmed: 28554731
Proc Natl Acad Sci U S A. 2014 Dec 23;111(51):18201-6
pubmed: 25404306
RNA Biol. 2018 Feb 1;15(2):198-206
pubmed: 29171334
Mol Cell Biol. 2011 Feb;31(4):736-43
pubmed: 21149580
Science. 2016 Sep 23;353(6306):
pubmed: 27708011
J Biol Chem. 2008 Dec 12;283(50):35186-98
pubmed: 18854321
Cell Rep. 2014 Apr 10;7(1):281-92
pubmed: 24656821
Nucleic Acids Res. 2014 Nov 10;42(20):12352-66
pubmed: 25332402
Nat Chem. 2014 Jan;6(1):75-80
pubmed: 24345950
Mol Cell. 2012 Jun 8;46(5):674-90
pubmed: 22681889
Nat Rev Genet. 2011 Aug 18;12(9):641-55
pubmed: 21850044
Nucleic Acids Res. 2013 Jul;41(12):6222-31
pubmed: 23620292
Nat Methods. 2016 Oct;13(10):841-4
pubmed: 27571552
J Biol Chem. 2005 Nov 18;280(46):38117-20
pubmed: 16150737
Nature. 2014 Sep 4;513(7516):65-70
pubmed: 25079319
Blood. 2012 May 3;119(18):4291-300
pubmed: 22422825
Nucleic Acids Res. 2015 Oct 15;43(18):8627-37
pubmed: 26350216
Cell. 2012 Jun 8;149(6):1393-406
pubmed: 22658674
Nucleic Acids Res. 2013 Jun;41(11):5898-911
pubmed: 23609544
Trends Cell Biol. 2016 Sep;26(9):668-679
pubmed: 27289443
Bioinformatics. 2010 Mar 15;26(6):841-2
pubmed: 20110278
Nucleic Acids Res. 2018 Nov 30;46(21):11592-11604
pubmed: 30256975
Mol Cell. 2017 Oct 5;68(1):144-157.e5
pubmed: 28965817
Mol Cell. 2018 Feb 15;69(4):622-635.e6
pubmed: 29429924

Auteurs

Markus Sauer (M)

Department of Biochemistry, Biocenter, University of Würzburg, 97074, Würzburg, Germany.
European Research Institute for the Biology of Ageing (ERIBA), University Medical Center Groningen, University of Groningen, 9713 AV, Groningen, The Netherlands.
Department of Oncology, Hematology and Rheumatology, University Hospital Bonn, 53127, Bonn, Germany.

Stefan A Juranek (SA)

Department of Oncology, Hematology and Rheumatology, University Hospital Bonn, 53127, Bonn, Germany.

James Marks (J)

Laboratory of Muscle Stem Cells and Gene Regulation, National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH, Bethesda, MD, 20892, USA.

Alessio De Magis (A)

Department of Oncology, Hematology and Rheumatology, University Hospital Bonn, 53127, Bonn, Germany.

Hinke G Kazemier (HG)

European Research Institute for the Biology of Ageing (ERIBA), University Medical Center Groningen, University of Groningen, 9713 AV, Groningen, The Netherlands.

Daniel Hilbig (D)

Department of Oncology, Hematology and Rheumatology, University Hospital Bonn, 53127, Bonn, Germany.

Daniel Benhalevy (D)

Laboratory of Muscle Stem Cells and Gene Regulation, National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH, Bethesda, MD, 20892, USA.

Xiantao Wang (X)

Laboratory of Muscle Stem Cells and Gene Regulation, National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH, Bethesda, MD, 20892, USA.

Markus Hafner (M)

Laboratory of Muscle Stem Cells and Gene Regulation, National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH, Bethesda, MD, 20892, USA. markus.hafner@nih.gov.

Katrin Paeschke (K)

Department of Biochemistry, Biocenter, University of Würzburg, 97074, Würzburg, Germany. katrin.paeschke@ukbonn.de.
European Research Institute for the Biology of Ageing (ERIBA), University Medical Center Groningen, University of Groningen, 9713 AV, Groningen, The Netherlands. katrin.paeschke@ukbonn.de.
Department of Oncology, Hematology and Rheumatology, University Hospital Bonn, 53127, Bonn, Germany. katrin.paeschke@ukbonn.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH